SI-BONE Inc
Joyce Goto brings over 20 years of financial management and accounting experience to SI-BONE. Prior to joining SI-BONE, Ms. Goto was the chief accounting officer at BioPharmX, a public, specialty pharmaceutical company focused on dermatology indications, until its acquisition by Timber Pharmaceuticals. Prior to this role, she held various accounting and finance positions at publicly-traded manufacturing companies, including MoSys, Pinnacle Systems and Virage Logic. Ms. Goto started her career at Deloitte, a public accounting firm. She holds a Bachelor of Science degree from Cal Poly, San Luis Obispo, and is a certified public accountant.
This person is not in any offices
SI-BONE Inc
2 followers
SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.